Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition

[1] Mora AL(2017)Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease Nat Rev Drug Discov 16 755-772

[2] Rojas M(2019)Developmental pathways in the pathogenesis of lung fibrosis Mol. Aspects. Med 65 56-69

[3] Pardo A(2017)Idiopathic pulmonary fibrosis Lancet. 389 1941-1952

[4] Selman M(1974)The pathogenesis of bleomycin-induced pulmonary fibrosis in mice Am. J. Pathol 77 185-197

[5] Chanda D(2015)Phenyl butyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis Toxicology Letters 232 213-220

[6] Otoupalova E(2015)Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions Pharmacol Res 97 122-130

[7] Smith SR(2008)The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 40 362-382

[8] Volckaert T(2011)Modeling pulmonary fibrosis with bleomycin Curr. Opin. Pulm. Med 17 355-361

[9] De Langhe SP(2018)Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis J Cell Mol Med 22 4354-4365

[10] Thannickal VJ(2019)Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis J Cell Mol Med 23 3583-3596

[1] Mora AL(2017)Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease Nat Rev Drug Discov 16 755-772

[2] Rojas M(2019)Developmental pathways in the pathogenesis of lung fibrosis Mol. Aspects. Med 65 56-69

[3] Pardo A(2017)Idiopathic pulmonary fibrosis Lancet. 389 1941-1952

[4] Selman M(1974)The pathogenesis of bleomycin-induced pulmonary fibrosis in mice Am. J. Pathol 77 185-197

[5] Chanda D(2015)Phenyl butyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis Toxicology Letters 232 213-220

[6] Otoupalova E(2015)Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions Pharmacol Res 97 122-130

[7] Smith SR(2008)The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 40 362-382

[8] Volckaert T(2011)Modeling pulmonary fibrosis with bleomycin Curr. Opin. Pulm. Med 17 355-361

[9] De Langhe SP(2018)Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis J Cell Mol Med 22 4354-4365

[10] Thannickal VJ(2019)Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis J Cell Mol Med 23 3583-3596